News & Updates

SBRT as effective as Y90 for HCC, but cheaper
SBRT as effective as Y90 for HCC, but cheaper
29 Mar 2024

Use of either stereotactic body radiotherapy (SBRT) or yttrium-90 (Y90) is effective in the management of hepatocellular carcinoma (HCC), resulting in similar overall and progression-free survival, reports a study. However, Y90 is more expensive than SBRT.

SBRT as effective as Y90 for HCC, but cheaper
29 Mar 2024